Zydus Sees Revlimid Generic Revenues Beyond Q4 As It Waits For Antitrust Suit To Play Out

Acquires Teva Group API Maker Watson

Growth Story
Zydus Is Planning For Growth, But Will Generic Revlimid Cast A Shadow • Source: Shutterstock

More from Business

More from Scrip